DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.
Abroad (travel likely)RecruitingPHASE2, PHASE3
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Conditions
Haematological Malignancy · Melanoma · Thyroid Cancer, Papillary · Ovarian Neoplasms · Colorectal Neoplasms · Laryngeal Neoplasms · Carcinoma, Non-Small-Cell Lung · Glioma · Multiple Myeloma · Erdheim-Chester Disease · Thyroid Carcinoma, Anaplastic · Solid Tumour
Locations
- Belfast City Hospital, Belfast, United Kingdom
- University Hospital Birmingham, Birmingham, United Kingdom
- Bristol Haematology and Oncology Centre, Bristol, United Kingdom
- Addenbrooke's Hospital, Cambridge, United Kingdom
- Velindre Cancer Centre, Cardiff, United Kingdom
- Western General Hospital, Edinburgh, United Kingdom
- The Beatson Hospital, Glasgow, United Kingdom
- Leicester Royal Infirmary, Leicester, United Kingdom
- University College London Hospital, London, United Kingdom
- Guy's Hospital, London, United Kingdom
- The Christie Hospital, Manchester, United Kingdom
- Clatterbridge Cancer Centre, Metropolitan Borough of Wirral, United Kingdom
- Freeman Hospital, Newcastle, United Kingdom
- Churchill Hospital, Oxford, United Kingdom
- Weston Park Hospital, Sheffield, United Kingdom
- Southampton General Hospital, Southampton, United Kingdom